Clinical impact, costs, and cost-effectiveness of expanded severe acute respiratory syndrome coronavirus 2 testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - Clinical Infectious …, 2021 - academic.oup.com
Background We projected the clinical and economic impact of alternative testing strategies
on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a …
被引用次数：83 相关文章
[PDF] scienceopen.com

[PDF][PDF] Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs, C Flanagan… - scienceopen.com
1 SUPPLEMENTARY MATERIAL Clinical Impact, Costs, and Cost-Effectiveness of
Expanded SARS-CoV-2 Testing in Massachusetts Anne M. Page 1 1 SUPPLEMENTARY …
[PDF] semanticscholar.org

[PDF][PDF] Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - Clinical Infectious …, 2021 - pdfs.semanticscholar.org
Background. We projected the clinical and economic impact of alternative testing strategies
on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a …
[HTML] nih.gov

[HTML][HTML] Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - … Diseases: An Official …, 2021 - ncbi.nlm.nih.gov
Background We projected the clinical and economic impact of alternative testing strategies
on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a …
[PDF] wits.ac.za

[PDF][PDF] Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - Clinical Infectious …, 2021 - wiredspace.wits.ac.za
Background. We projected the clinical and economic impact of alternative testing strategies
on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a …

Clinical impact, costs, and cost-effectiveness of expanded Severe acute respiratory syndrome Coronavirus 2 testing in Massachusetts.

AM Neilan, E Losina, AC Bangs, C Flanagan… - 2021 - cabidigitallibrary.org
Background: We projected the clinical and economic impact of alternative testing strategies
on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a …

Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - … : the preprint server …, 2020 - pubmed.ncbi.nlm.nih.gov
Background We projected the clinical and economic impact of alternative testing strategies
on COVID-19 incidence and mortality in Massachusetts using a microsimulation model …
[HTML] europepmc.org

[HTML][HTML] Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs, C Flanagan… - 2020 - europepmc.org
Background We projected the clinical and economic impact of alternative testing strategies
on COVID-19 incidence and mortality in Massachusetts using a microsimulation model …

Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - Clinical Infectious …, 2020 - discovery.ucl.ac.uk
BACKGROUND: We projected the clinical and economic impact of alternative testing
strategies on COVID-19 incidence and mortality in Massachusetts using a microsimulation …
[PDF] oup.com

[PDF][PDF] Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts

AM Neilan, E Losina, AC Bangs… - Clinical Infectious …, 2021 - academic.oup.com
Background We projected the clinical and economic impact of alternative testing strategies
on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a …